These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 31926244)

  • 21. The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinoma.
    Xu F; Guan Y; Xue L; Huang S; Gao K; Yang Z; Chong T
    BMC Cancer; 2020 Dec; 20(1):1207. PubMed ID: 33287763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma.
    Wang C; Li Y; Chu CM; Zhang XM; Ma J; Huang H; Wang YN; Hong TY; Zhang J; Pan XW; Zheng JC; Jiang N; Hu CY; Ma X; Sun YH; Cui XG
    EBioMedicine; 2019 Jan; 39():255-264. PubMed ID: 30558998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J
    Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of Ferritin Heavy Chain (FTH1) Expression in Diagnosis and Prognosis of Renal Cell Carcinoma.
    Huang H; Qiu Y; Huang G; Zhou X; Zhou X; Luo W
    Med Sci Monit; 2019 May; 25():3700-3715. PubMed ID: 31104064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
    Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
    J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fc receptor-like A promotes malignant behavior in renal cell carcinoma and correlates with tumor immune infiltration.
    Liu JP; Jiang YF; Liu JW; Tian CJ; Lin YZ; Yang YZ; Zhang ZK; Fang YL; Huang B; Lin H
    Cancer Med; 2024 Aug; 13(15):e70072. PubMed ID: 39108036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer.
    Wan YP; Xi M; He HC; Wan S; Hua W; Zen ZC; Liu YL; Zhou YL; Mo RJ; Zhuo YJ; Luo HW; Jiang FN; Zhong WD
    Oncol Res Treat; 2017; 40(1-2):15-20. PubMed ID: 28118628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low NR3C2 levels correlate with aggressive features and poor prognosis in non-distant metastatic clear-cell renal cell carcinoma.
    Zhao Z; Zhang M; Duan X; Deng T; Qiu H; Zeng G
    J Cell Physiol; 2018 Oct; 233(10):6825-6838. PubMed ID: 29693713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression.
    Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):39-52. PubMed ID: 28993942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma.
    Gui CP; Wei JH; Chen YH; Fu LM; Tang YM; Cao JZ; Chen W; Luo JH
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analysis of single-cell RNA-seq and bulk RNA-seq revealed the heterogeneity and convergence of the immune microenvironment in renal cell carcinoma.
    Lv S; Tao L; Liao H; Huang Z; Lu Y
    Funct Integr Genomics; 2023 Jun; 23(2):193. PubMed ID: 37264263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinformatic profiling identifies prognosis-related genes in the immune microenvironment of endometrial carcinoma.
    Cheng P; Ma J; Zheng X; Zhou C; Chen X
    Sci Rep; 2021 Jun; 11(1):12608. PubMed ID: 34131259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the expression of CARMA3 as a prognostic tumor marker in renal cell carcinoma.
    Wu GL; Yuan JL; Huang XD; Rong JF; Zhang LX; Liu YP; Wang FL
    Tumour Biol; 2013 Dec; 34(6):3431-5. PubMed ID: 23771851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WWOX protein expression varies among RCC histotypes and downregulation of WWOX protein correlates with less-favorable prognosis in clear RCC.
    Lin JT; Tzai TS; Liao CY; Wang JS; Wu TT; Wang HY; Wu CH; Yu CC; Lu PJ
    Ann Surg Oncol; 2013 Jan; 20(1):193-9. PubMed ID: 22555346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma.
    Tripathi A; Lin E; Xie W; Flaifel A; Steinharter JA; Stern Gatof EN; Bouchard G; Fleischer JH; Martinez-Chanza N; Gray C; Mantia C; Thompson L; Wei XX; Giannakis M; McGregor BA; Choueiri TK; Agarwal N; McDermott DF; Signoretti S; Harshman LC
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33177176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
    Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
    BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 17-Gene Signature Predicted Prognosis in Renal Cell Carcinoma.
    Li F; Hu W; Zhang W; Li G; Guo Y
    Dis Markers; 2020; 2020():8352809. PubMed ID: 32184905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploration of immune-related genes in high and low tumor mutation burden groups of chromophobe renal cell carcinoma.
    Li L; Chen X; Hao L; Chen Q; Liu H; Zhou Q
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32662515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma.
    Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y
    Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.